Results 231 to 240 of about 568,827 (356)

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Prescription opioids among older adults: ten years of data across five countries. [PDF]

BMC Geriatr, 2022
Hamina A, Muller AE, Clausen T, Skurtveit S, Hesse M, Tjagvad C, Thylstrup B, Odsbu I, Zoega H, Jónsdóttir HL, Taipale H.   +10 more
europepmc   +1 more source

A meta‐analysis of sexual orientation inequities in substance use among youth

Addiction, EarlyView.
Abstract Background and Aims Sexual minority youth report significantly higher rates of substance use than heterosexual youth, yet a comprehensive and systematic evaluation and synthesis of the magnitude of this inequity has not been conducted. The purpose of this study was to conduct a meta‐analysis to assess the magnitude of overall inequities in ...
Ethan H. Mereish, Hyemin Lee, Jeremy T. Goldbach, Sophie Hathaway, Emily A. Hennessy   +4 more
wiley   +1 more source

Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents. [PDF]

Explor Res Clin Soc Pharm
Gac B, Tavares K, Yakubi H, Khan H, Apollonio DE, Crosbie E.   +5 more
europepmc   +1 more source

Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017. [PDF]

Oncologist, 2021
Zhang H, Paice J, Portenoy R, Bruera E, Reid MC, Bao Y.   +5 more
europepmc   +1 more source

The association of methadone use with physical function and frailty among persons who inject drugs

Addiction, EarlyView.
Abstract Background and Aims Persons who inject drugs (PWID) experience a high burden of early‐onset frailty, primarily due to multifactorial causes such as infections (human immunodeficiency virus [HIV], hepatitis C virus [HCV]), substance use, and polypharmacy.
Grace L. Kulik, Hsing‐Yu Hsu, Jacqueline Rudolph, Yutong Jiang, Kristine M. Erlandson, Damani A. Piggott, Shruti Mehta, Jeremy D. Walston, Gregory Kirk, Todd T. Brown, Jing Sun   +10 more
wiley   +1 more source

Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids. [PDF]

Oncologist
Kang JH, Lee KH, Huh SJ, Shin SH, Kim IH, Hwang IG, Koo DH, Lee D, Koh SJ, Seo S, Lee GJ, Chun SH, Ji JH, Oh SY, Choi JW, Go SI.   +15 more
europepmc   +1 more source

Patterns in Prescription Opioids, Benzodiazepines, and Stimulants Filled by Pregnant Medicaid Beneficiaries.

JAMA Pediatr, 2023
Meinhofer A, Martinez ML, Palmsten K.
europepmc   +1 more source

Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies. [PDF]

Can Pharm J (Ott), 2022
Qiu Hua Chen A.
europepmc   +1 more source

Weaning Drug Manufacturers Off Their Painkiller: Creating an Exception to the Learned Intermediary Doctrine in Light of the Opioid Crisis [PDF]

, 2019
Max Roberts
core   +1 more source